Literature DB >> 6136900

The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors.

P Robberecht, M Delhaye, G Taton, P De Neef, M Waelbroeck, J M De Smet, J L Leclerc, P Chatelain, J Christophe.   

Abstract

Beta-adrenergic receptors were characterized in a particulate fraction of human auricles obtained from patients operated upon for coronary insufficiency or valvular disease. [125I] Hydroxybenzylpindolol binding was evaluated in terms of kinetics; KD and Bmax values; and inhibition of binding in the presence of 10 microM GTP and of increasing concentrations of four nonselective agonists giving a Hill coefficient of 1 (isoproterenol, salbutamol, fenoterol, and epinephrine), of two nonselective antagonists giving a Hill coefficient of 1 (pindolol and propranolol), and of a series of selective drugs giving a Hill coefficient of 0.60-0.72 that included three beta 1-selective antagonists (practolol, metoprolol, and atenolol) and two beta 2- selective agonists (procaterol and zinterol). KD values for all drugs were compatible with the coexistence in membranes from human auricles of beta 1- and beta 2-adrenergic receptors, the relative proportions of receptors of each subclass being approximately the same.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6136900

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Characterization and autoradiographic localization of beta-adrenoceptor subtypes in human cardiac tissues.

Authors:  B F Buxton; C R Jones; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1987-10       Impact factor: 8.739

2.  Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.

Authors:  A Mugelli; S Amerini; P De Bonfioli Cavalcabo; E Cerbai; S Visentin
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

3.  Binding of beta 1-adrenoceptor antagonist [3H]CGP 26505 in rat cerebral cortex and sinus atrial node.

Authors:  G Chiellini; G Giannaccini; C Martini; A Lucacchini
Journal:  Neurochem Res       Date:  1996-10       Impact factor: 3.996

4.  Atypical characteristics of the beta-adrenoceptor mediating cyclic AMP generation and lipolysis in the rat adipocyte.

Authors:  D Bojanic; J D Jansen; S R Nahorski; J Zaagsma
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

Review 5.  Beta-adrenoceptor blockade and exercise. An update.

Authors:  M A Van Baak
Journal:  Sports Med       Date:  1988-04       Impact factor: 11.136

6.  Cardiac ventricular beta 2-adrenoceptors in guinea-pigs and rats are localized on the coronary endothelium.

Authors:  M Freissmuth; V Hausleithner; S Nees; M Böck; W Schütz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

7.  Effects of the beta 2-adrenoceptor agonists fenoterol and salbutamol on force of contraction in isolated human ventricular myocardium.

Authors:  A Mügge; D Posselt; U Reimer; W Schmitz; H Scholz
Journal:  Klin Wochenschr       Date:  1985-01-02

8.  Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective beta-blockade.

Authors:  B W Johansson; R Dziamski
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

9.  Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.

Authors:  A J Kaumann; H Lemoine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-04       Impact factor: 3.000

10.  The role of cyclic AMP in the positive inotropic effect mediated by beta 1- and beta 2-adrenoceptors in isolated human right atrium.

Authors:  K Ikezono; M C Michel; H R Zerkowski; J J Beckeringh; O E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.